Hospital
Garnet Health Medical Center Catskills
Garnet Health Medical Center Catskills was paid $21.96M by Medicaid between Jan 2018 and Dec 2024, across 188 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.
33Billing provider infoGARNET HEALTH MEDICAL CENTER CATSKILLS
HARRIS, NY 12742
HARRIS, NY 12742
33aNPI1710977012assigned 10/27/2005
33bProvider typeRural Acute Care Hospital
28Total paid$21.96M
24GClaims361,900
24DCodes billed188
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rural Acute Care Hospital providers in New York
Rank by total paid#2 of 7
Median peer was paid$13.87M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,124 | $20K | |
| 2019 | 23,638 | $793K | |
| 2020 | 62,730 | $2.51M | |
| 2021 | 72,290 | $3.19M | |
| 2022 | 77,108 | $5.90M | |
| 2023 | 73,020 | $5.88M | |
| 2024incomplete | 50,990 | $3.66M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 26,302 | 24,386 | $5.01M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 18,400 | 16,707 | $2.62M |
| 80048 | Basic metabolic panel (calcium, ionized) | 7.6% | 33,088 | 13,908 | $1.68M |
| 96361 | Intravenous infusion, hydration; each additional hour | 5.7% | 5,077 | 4,713 | $1.26M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.7% | 3,240 | 3,153 | $1.03M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.4% | 4,580 | 3,627 | $956K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.0% | 2,879 | 2,800 | $882K |
| 97602 | 3.2% | 1,173 | 545 | $713K | |
| 80053 | Comprehensive metabolic panel | 3.2% | 18,561 | 15,691 | $705K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3.0% | 4,326 | 1,012 | $659K |
| 36415 | Collection of venous blood by venipuncture | 2.4% | 45,749 | 17,424 | $535K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 2,449 | 2,346 | $483K |
176 more codes
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.9% | 909 | $418K |
| 88342 | 1.9% | 434 | $418K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.9% | 1,035 | $414K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.5% | 2,373 | $339K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.4% | 879 | $318K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.4% | 4,864 | $303K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 765 | $239K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,127 | $210K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 908 | $166K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,875 | $165K |
| 80076 | <1% | 11,505 | $148K | |
| 99285 | Emergency room visit (most serious) | <1% | 982 | $140K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,602 | $134K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,215 | $129K |
| 86850 | <1% | 2,173 | $127K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,686 | $112K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 172 | $105K |
| 12001 | <1% | 227 | $103K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 54 | $98K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 305 | $62K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 877 | $61K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 216 | $57K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 700 | $54K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,869 | $54K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 54 | $54K |
| 83880 | <1% | 1,636 | $53K | |
| 86901 | <1% | 2,286 | $51K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,190 | $51K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 578 | $48K |
| 76830 | Ultrasound, transvaginal | <1% | 633 | $45K |
| 76801 | <1% | 497 | $44K | |
| 86900 | <1% | 2,286 | $44K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 998 | $39K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,736 | $37K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 361 | $33K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,923 | $30K |
| 80061 | Lipid panel | <1% | 5,383 | $29K |
| 70496 | <1% | 84 | $28K | |
| 85055 | <1% | 796 | $28K | |
| 93970 | <1% | 51 | $28K | |
| 86618 | <1% | 1,126 | $27K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 17,967 | $26K |
| 93971 | <1% | 173 | $22K | |
| 29125 | <1% | 101 | $21K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 976 | $19K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,492 | $17K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,455 | $15K |
| 90715 | <1% | 582 | $14K | |
| 76642 | <1% | 523 | $11K | |
| 82607 | <1% | 974 | $11K | |
| 83655 | <1% | 880 | $11K | |
| 84439 | <1% | 1,504 | $11K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,602 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,952 | $8K |
| 85027 | <1% | 3,205 | $7K | |
| 82803 | <1% | 219 | $7K | |
| 84436 | <1% | 1,479 | $7K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 94 | $7K |
| 76775 | <1% | 89 | $7K | |
| 82728 | <1% | 603 | $7K | |
| 85610 | <1% | 3,746 | $7K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,813 | $6K |
| G0378 | Hospital observation service, per hour | <1% | 120 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,031 | $6K |
| 12011 | <1% | 13 | $6K | |
| 97162 | <1% | 51 | $6K | |
| 12002 | <1% | 13 | $6K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 623 | $5K |
| 10060 | <1% | 12 | $5K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 39 | $4K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 286 | $4K |
| 83735 | <1% | 4,008 | $4K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 12 | $4K |
| 84703 | <1% | 3,773 | $4K | |
| 86803 | <1% | 375 | $3K | |
| 76000 | <1% | 14 | $3K | |
| 84479 | <1% | 992 | $3K | |
| 84702 | <1% | 983 | $3K | |
| 29515 | <1% | 13 | $3K | |
| 81001 | <1% | 4,504 | $3K | |
| 83540 | <1% | 620 | $2K | |
| 71250 | <1% | 24 | $2K | |
| 85730 | <1% | 2,666 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 37 | $2K |
| 87077 | <1% | 604 | $2K | |
| 86140 | <1% | 914 | $2K | |
| 85651 | <1% | 1,398 | $2K | |
| 83550 | <1% | 537 | $2K | |
| 84153 | <1% | 124 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,042 | $2K |
| 87081 | <1% | 1,224 | $2K | |
| 96376 | <1% | 1,518 | $2K | |
| 81003 | <1% | 3,385 | $1K | |
| 82550 | <1% | 3,438 | $1K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 2,121 | $1K |
| 86480 | <1% | 28 | $1K | |
| 70486 | <1% | 12 | $1K | |
| 96367 | <1% | 38 | $1K | |
| 74018 | <1% | 536 | $1K | |
| 83690 | <1% | 2,417 | $1K | |
| 84484 | <1% | 4,448 | $1K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 38 | $1K |
| 84403 | <1% | 41 | $1K | |
| 83970 | <1% | 25 | $896.47 | |
| 87420 | <1% | 307 | $862.84 | |
| 82378 | <1% | 58 | $850.53 | |
| 84480 | <1% | 198 | $818.96 | |
| 86617 | <1% | 25 | $623.70 | |
| 82784 | <1% | 54 | $623.55 | |
| 87340 | <1% | 93 | $610.53 | |
| 87186 | <1% | 254 | $602.23 | |
| 86592 | <1% | 217 | $581.07 | |
| 83605 | <1% | 1,844 | $537.06 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 32 | $524.63 |
| 82570 | <1% | 145 | $510.37 | |
| 87040 | <1% | 1,729 | $479.34 | |
| 80320 | <1% | 1,391 | $479.23 | |
| 73630 | <1% | 66 | $466.49 | |
| 73610 | <1% | 137 | $404.90 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 579 | $399.46 |
| 80361 | <1% | 109 | $395.09 | |
| OP270 | <1% | 14 | $389.43 | |
| 82962 | <1% | 677 | $359.54 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 12 | $320.31 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 13 | $318.12 |
| 86431 | <1% | 66 | $281.75 | |
| 86666 | <1% | 25 | $242.02 | |
| 86430 | <1% | 73 | $241.70 | |
| 72100 | <1% | 51 | $239.46 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,034 | $232.00 |
| 82043 | <1% | 61 | $226.05 | |
| 82977 | <1% | 59 | $214.20 | |
| 76536 | <1% | 12 | $210.90 | |
| 82150 | <1% | 454 | $203.24 | |
| 36416 | <1% | 110 | $193.90 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 12 | $186.00 |
| 86765 | <1% | 14 | $176.45 | |
| 86709 | <1% | 17 | $152.77 | |
| 80365 | <1% | 48 | $148.00 | |
| 86705 | <1% | 16 | $139.98 | |
| 82248 | <1% | 28 | $135.19 | |
| 80349 | <1% | 38 | $122.62 | |
| 73030 | <1% | 41 | $107.27 | |
| OP250 | <1% | 34 | $105.17 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,272 | $101.78 |
| 86060 | <1% | 16 | $86.35 | |
| 80143 | <1% | 511 | $85.56 | |
| 73110 | <1% | 21 | $76.02 | |
| 80179 | <1% | 481 | $66.74 | |
| 82948 | <1% | 239 | $59.16 | |
| 85379 | <1% | 92 | $56.53 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,095 | $56.19 |
| 86038 | <1% | 12 | $55.71 | |
| 73130 | <1% | 41 | $52.25 | |
| 82746 | <1% | 13 | $50.75 | |
| 84550 | <1% | 14 | $43.40 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,217 | $41.78 |
| 80329 | <1% | 159 | $33.59 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 75 | $33.00 |
| 84100 | <1% | 14 | $30.40 | |
| J2704 | Injection, propofol, 10 mg | <1% | 909 | $29.23 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 216 | $17.68 |
| 74019 | <1% | 12 | $9.90 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 222 | $4.46 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 108 | $1.17 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 597 | $0.91 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 26 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 13 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 19 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 169 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 146 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 138 | $0.00 |
| 87147 | 0% | 62 | $0.00 | |
| 73090 | 0% | 12 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 78 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHEUERMANN, WILLIAM (VICE PRESIDENT, REVENUE STRATEGY &)
| Provider | Location | Paid |
|---|---|---|
| Garnet Health Medical Center | Middletown, NY | $45.17M |
| Garnet Health Medical Center Catskills | Callicoon, NY | $941K |
| Garnet Health Medical Center | Middletown, NY | $44K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.